Table 1 Demographic features, cardiovascular risk factors, medications and laboratory test findings among the case and control groups.

^aAge; Mean ± SD

53.8 ± 2.6

61.13 ± 2.6

0.03

Gender

Male

9 (45%)

17 (81%)

0.01

Female

11 (55%)

4 (19%)

^aBMI; Kg/m²

25.3 ± 8.8

26.4 ± 2.0

0.69

Risk factor

Diabetes; n (%)

0 (0%)

0 (0%)

1

Hypertension; n (%)

5 (25%)

10 (47.1%)

0.13

Smoking; n (%)

2 (10%)

6 (26.6%)

0.13

Dyslipidemia; n (%)

1 (5%)

6 (28.6%)

0.09

Family history; n (%)

5 (25%)

4 (19%)

0.64

Anemia; n (%)

2 (10%)

4 (19%)

1

Chronic kidney disease; n (%)

0 (0%)

1 (4.8%)

1

Cerebellar stroke; n (%)

2 (10%)

1 (4.8%)

0.60

Thyroid disease; n (%)

1 (5%)

1 (4.8%)

0.57

Gastrointestinal bleeding; n (%)

1 (5%)

2 (9.6%)

0.51

Pulmonary disease; n (%)

0 (0%)

3 (14.3%)

0.23

Medication consumption

Aspirin; n (%)

9 (45%)

19 (90%)

0.002

Statins; n (%)

7 (35%)

16 (76%)

0.01

ACE inhibitors & ARB; n (%)

9 (45%)

15 (71%)

0.1

Beta-Blocker

13 (65%)

14 (66%)

1

Calcium channel blockers

2 (10%)

2 (9%)

1

Nitrates

1 (5%)

10 (47%)

0.003

Laboratory tests

^aFBS, mg/dL

97.13 ± 8.4

95.10 ± 0.9

0.469

^aLDL-C, mg/dL

89.22 ± 8.8

87.26 ± 2.4

0.733

^aHDL-C, mg/dL

34.5 ± 2.2

33.4 ± 0.2

0.42

^aTG, mg/dL

125.5 ± 9.0

110.32 ± 0.5

0.23

^aCRP, mg/L

5.7 ± 4.0

9.5 ± 5.7

0.81